Pro Pharma Research Organization shows up when manufacturers search for a Latin American registration holder or sanitary-registration partner. This article uses only what Pro Pharma Research Organization publishes on its own site (propharmaresearch.com/index.php/servicio/servicios-representante-empresa-titular-registro-sanitario-mexico), then compares it with multi-country market access from bioaccess®. It is a practitioner comparison, not a teardown.
What Pro Pharma Research Organization publishes
Pro Pharma Research Organization is a Mexican company that publishes a service page for acting as company representative and titular del registro sanitario (TRS) before COFEPRIS. The page covers pharmaceuticals, medical devices and other health products, and COFEPRIS liaison. It is broader than devices.
Pro Pharma Research Organization vs bioaccess®
| Dimension | Pro Pharma Research Organization | bioaccess® |
|---|---|---|
| Public product | Mexico titular del registro / company representative before COFEPRIS | Registration, in-country holder, certified translations, tecnovigilancia as holder (import shipments quoted separately) |
| Geography | Mexico | Published pricing in Mexico, Colombia, Brazil, Peru and Argentina; other markets quoted case by case |
| Public pricing | None published | Two-part: one-time registration fee per country by class, then an annual holder fee from year 2 (rate card) |
| Holder vs distributor | See the provider’s own terms | Holder under contract (own Colombian entity in Colombia; local partner elsewhere), with defined transfer provisions; the registration is never leverage |
| Bridge from a clinical trial | None published | Same firm can run the LATAM clinical trial and then hold the commercial registration |
Where each one fits
If Mexico is the only market and you want a local titular that also handles pharma SKUs, Pro Pharma publishes that service.
bioaccess® market access is a different product. bioaccess® registers already FDA-cleared or CE-marked devices and acts as their registration holder under contract (in Colombia through its own Colombian entity; elsewhere with its local partner) across Latin American markets, including COFEPRIS, ANVISA, INVIMA, ANMAT, ISP and DIGEMID. Pricing is two-part pricing: a one-time registration fee per country by device class, then a lower annual holder fee from year 2 (published for Mexico, Colombia, Brazil, Peru and Argentina on the rate card). Importer-of-record shipments are quoted separately. The registration is held for the manufacturer’s benefit, with defined transfer provisions if you ever change partners or set up your own entity.
One country and one local partner is enough? Hire the firm that publishes that job. Several LATAM labels under one holder who is not your distributor? Start at bioaccess® market access, read the LATAM importer of record guide, try the market-access calculator, or request a registration quote.
Competitor facts from the Pro Pharma Research Organization public pages linked above, reviewed for bioaccess® competitive research (Aug–Oct 2026). Claims are theirs. No invented clients, prices or contacts.